2012-10-31 14:07:54 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to produce reports on a company's attractiveness to long-term investors.

Ilhavo, Portugal — SADIF Investment Analytics, announces a new summary due diligence report covering the following companies:

Report Summary for: Ping An Bank Co Ltd is a below average quality company with a positive outlook. Ping An Bank Co Ltd has strong business growth and is run by passable management. The trend in Ping An Bank Co Ltd fair value exchange rate against its closest rated-competitor, Bank of China Limited, has been stable over the past 2 weeks. When compared to its closest competitor, Ping An Bank Co Ltd shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment

Analytics at:
www.sadifanalytics.com/stockmarks/company-21-1

Report Summary for: Lu Thai Textile Co., Ltd. is an above average quality company with a neutral outlook. Lu Thai Textile Co., Ltd. has medium business growth and is run by efficient management. The trend in Lu Thai Textile Co., Ltd. fair value exchange rate against its closest rated-competitor, Shandong Demian Incorporated Company, has been depreciating over the past 2 weeks. When compared to its closest competitor, Lu Thai Textile Co., Ltd. shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-200726

Report Summary for: Yantai Changyu Pioneer Wine Company Ltd is a high quality company with a neutral outlook. Yantai Changyu Pioneer Wine Company Ltd has strong business growth and is run by efficient management. The trend in Yantai Changyu Pioneer Wine Company Ltd fair value exchange rate against its closest rated-competitor, Anhui Golden Seed Winery Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, Yantai Changyu Pioneer Wine Company Ltd shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-200869

Report Summary for: Jiangsu Yuyue Medical Equipment & Supply is an above average quality company with a neutral outlook. Jiangsu Yuyue Medical Equipment & Supply has strong business growth and is run by efficient management. The trend in Jiangsu Yuyue Medical Equipment & Supply fair value exchange rate against its closest rated-competitor, Shandong Pharmaceutical Glass Co., Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Jiangsu Yuyue Medical Equipment & Supply shows less overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-2223

Report Summary for: Weichai Power Co., Ltd. is an above average quality company with a neutral outlook. Weichai Power Co., Ltd. has medium business growth and is run by efficient management. The trend in Weichai Power Co., Ltd. fair value exchange rate against its closest rated-competitor, Chongqing Changan Automobile Company Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Weichai Power Co., Ltd. shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-338

Report Summary for: Hua Xia Bank Co., Limited is a below average quality company with a positive outlook. Hua Xia Bank Co., Limited has strong business growth and is run by efficient management. The trend in Hua Xia Bank Co., Limited fair value exchange rate against its closest rated-competitor, Bank of Communications Co Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Hua Xia Bank Co., Limited shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600015

Report Summary for: China Southern Airlines Limited is an above average quality company with a neutral outlook. China Southern Airlines Limited has medium business growth and is run by passable management. The trend in China Southern Airlines Limited fair value exchange rate against its closest rated-competitor, Shandong Airlines Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, China Southern Airlines Limited shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600029

Report Summary for: China United Telecommunications Corp Ltd is a below average quality company with a positive outlook. China United Telecommunications Corp Ltd has medium business growth and is run by mediocre management. The trend in China United Telecommunications Corp Ltd fair value exchange rate against its closest rated-competitor, Dingli Communications Corp Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, China United Telecommunications Corp Ltd shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600050

Report Summary for: Wuhan Humanwell Healthcare (Group)Co Ltd is an average quality company with a neutral outlook. Wuhan Humanwell Healthcare (Group)Co Ltd has strong business growth and is run by efficient management. The trend in Wuhan Humanwell Healthcare (Group)Co Ltd fair value exchange rate against its closest rated-competitor, Apeloa Company Limited, has been depreciating over the past 2 weeks. When compared to its closest competitor, Wuhan Humanwell Healthcare (Group)Co Ltd shows less overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600079

Report Summary for: Henan Taloph Pharmaceutical Stock Co., is a low quality company with a neutral outlook. Henan Taloph Pharmaceutical Stock Co., has medium business growth and is run by mediocre management. The trend in Henan Taloph Pharmaceutical Stock Co., fair value exchange rate against its closest rated-competitor, Shanghai Fudan Forward S&T Co., Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Henan Taloph Pharmaceutical Stock Co., shows greater overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600222

Report Summary for: Sichuan Di Kang Sci&Tech Pharm. Ind. Co. is an average quality company with a neutral outlook. Sichuan Di Kang Sci&Tech Pharm. Ind. Co. has medium business growth and is run by passable management. The trend in Sichuan Di Kang Sci&Tech Pharm. Ind. Co. fair value exchange rate against its closest rated-competitor, Zhejiang Hisoar Pharmaceutical Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, Sichuan Di Kang Sci&Tech Pharm. Ind. Co. shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600466

Report Summary for: Jiangsu Lianhuan Pharmaceutical Co. Ltd is a below average quality company with a positive outlook. Jiangsu Lianhuan Pharmaceutical Co. Ltd has medium business growth and is run by efficient management. The trend in Jiangsu Lianhuan Pharmaceutical Co. Ltd fair value exchange rate against its closest rated-competitor, Shanghai Furen Industrial (Group) Co., has been depreciating over the past 2 weeks. When compared to its closest competitor, Jiangsu Lianhuan Pharmaceutical Co. Ltd shows greater overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600513

Report Summary for: Kweichow Moutai Co., Ltd. is an above average quality company with a neutral outlook. Kweichow Moutai Co., Ltd. has strong business growth and is run by first class management. The trend in Kweichow Moutai Co., Ltd. fair value exchange rate against its closest rated-competitor, Lu Zhou Lao Jiao Co.,Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Kweichow Moutai Co., Ltd. shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600519

Report Summary for: Zhejiang Huahai Pharmaceutical Co., Ltd. is an average quality company with a neutral outlook. Zhejiang Huahai Pharmaceutical Co., Ltd. has strong business growth and is run by efficient management. The trend in Zhejiang Huahai Pharmaceutical Co., Ltd. fair value exchange rate against its closest rated-competitor, Henan Taloph Pharmaceutical Stock Co.,, has been depreciating over the past 2 weeks. When compared to its closest competitor, Zhejiang Huahai Pharmaceutical Co., Ltd. shows less overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600521

Report Summary for: GuiZhou YiBai Pharmaceutical Co., Ltd. is an average quality company with a neutral outlook. GuiZhou YiBai Pharmaceutical Co., Ltd. has medium business growth and is run by efficient management. The trend in GuiZhou YiBai Pharmaceutical Co., Ltd. fair value exchange rate against its closest rated-competitor, Tianjin Chase Sun Pharmaceutical Co Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, GuiZhou YiBai Pharmaceutical Co., Ltd. shows greater overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600594

Report Summary for: Topchoice Medical Corporation is an average quality company with a neutral outlook. Topchoice Medical Corporation has strong business growth and is run by efficient management. The trend in Topchoice Medical Corporation fair value exchange rate against its closest rated-competitor, Shan Dong Dong-E E-Jiao Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, Topchoice Medical Corporation shows less overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600763

Report Summary for: Maanshan Iron & Steel Company Limited is an average quality company with a neutral outlook. Maanshan Iron & Steel Company Limited has medium business growth and is run by mediocre management. The trend in Maanshan Iron & Steel Company Limited fair value exchange rate against its closest rated-competitor, Shandong Iron and Steel Co Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Maanshan Iron & Steel Company Limited shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600808

Report Summary for: Tianjin Capital Environmental Prtctn Grp is an average quality company with a neutral outlook. Tianjin Capital Environmental Prtctn Grp has medium business growth and is run by passable management. The trend in Tianjin Capital Environmental Prtctn Grp fair value exchange rate against its closest rated-competitor, Beijing Capital Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, Tianjin Capital Environmental Prtctn Grp shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600874

Report Summary for: Wuhan Jianmin Pharmaceutical Group Co. is a low quality company with a neutral outlook. Wuhan Jianmin Pharmaceutical Group Co. has weak business growth and is run by efficient management. The trend in Wuhan Jianmin Pharmaceutical Group Co. fair value exchange rate against its closest rated-competitor, Shanghai Furen Industrial (Group) Co., has been depreciating over the past 2 weeks. When compared to its closest competitor, Wuhan Jianmin Pharmaceutical Group Co. shows greater overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-600976

Report Summary for: ZTE Corporation is a below average quality company with a neutral outlook. ZTE Corporation has strong business growth and is run by mediocre management. The trend in ZTE Corporation fair value exchange rate against its closest rated-competitor, Shanghai Potevio Co Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, ZTE Corporation shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-21-63


About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering twenty four different markets and over 18,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.